GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
H

Huons Co 243070.KQ · KRW

Health Care · KOSDAQ · 🇰🇷 South Korea

Compare

15,690

-2.43%

Close of 9 Nov 2026, in KRW

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

At a glance

Figures in KRW, from our data supplier.

FY2025

Revenue

₩620.77bn

FY2016FY2025

Net income

₩42.66bn

FY2016FY2025

Free cash flow

₩20.69bn

FY2016FY2025

Shareholders' equity

₩373.91bn

FY2016FY2025

Income statement

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Revenue₩620.77bn₩590.23bn₩552.01bn₩492.39bn₩436.91bn₩406.68bn₩365.02bn₩328.60bn₩284.84bn₩168.97bn
Gross profit₩282.21bn₩285.22bn₩286.11bn₩268.00bn₩248.86bn₩219.85bn₩199.99bn₩181.55bn₩155.85bn₩89.28bn
Research and development₩41.80bn₩34.87bn₩32.88bn₩36.47bn₩30.90bn₩26.54bn₩25.29bn₩20.69bn₩19.86bn₩21.30bn
Operating income₩53.25bn₩38.55bn₩56.00bn₩37.89bn₩45.28bn₩54.12bn₩48.06bn₩48.34bn₩36.22bn₩19.33bn
Net income₩42.66bn₩29.45bn₩50.47bn₩22.44bn₩30.75bn₩55.58bn₩38.21bn₩45.23bn₩35.07bn₩15.33bn
Diluted earnings per share3,661.302,494.394,250.881,897.302,598.484,695.143,872.234,583.055,109.851,282.69

Balance sheet

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Total assets₩680.28bn₩606.29bn₩537.29bn₩472.63bn₩436.90bn₩416.50bn₩300.34bn₩251.37bn₩216.00bn₩179.34bn
Cash and short-term investments—₩68.87bn₩80.33bn₩84.62bn₩70.13bn₩119.78bn₩50.49bn₩37.35bn₩47.33bn₩22.47bn
Total liabilities₩265.42bn₩260.31bn₩206.87bn₩190.17bn₩170.80bn₩177.70bn₩105.83bn₩88.10bn₩93.31bn₩85.47bn
Debt₩82.32bn₩178.71bn₩124.61bn₩107.07bn₩79.58bn₩100.81bn₩36.46bn₩26.88bn₩36.06bn₩35.59bn
Shareholders' equity₩373.91bn₩345.97bn₩325.40bn₩282.46bn₩266.09bn₩238.80bn₩194.52bn₩163.27bn₩122.69bn₩93.88bn
Shares outstanding12m12m12m12m12m12m10m10m7m12m

Cash flow

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash from operations₩45.01bn₩52.56bn₩52.14bn₩32.02bn₩55.59bn₩46.51bn₩42.12bn₩20.88bn₩30.21bn₩43.38bn
Capital spending−₩24.32bn−₩84.21bn−₩44.77bn−₩41.32bn−₩40.69bn−₩37.72bn−₩19.26bn−₩10.28bn−₩8.53bn−₩6.10bn
Free cash flow₩20.69bn−₩31.65bn₩7.38bn−₩9.30bn₩14.90bn₩8.79bn₩22.86bn₩10.60bn₩21.67bn₩37.28bn
Dividends paid−₩12.25bn−₩7.47bn−₩10.65bn−₩6.46bn−₩5.87bn−₩6.28bn−₩6.53bn−₩3.71bn−₩3.71bn−₩3.71bn

Latest quarters

By quarter end

Jun 2026Mar 2026Dec 2025Sept 2025Jun 2025Mar 2025Dec 2024Sept 2024
Revenue₩146.98bn₩141.87bn₩165.19bn₩153.72bn₩156.03bn₩145.84bn₩146.62bn₩146.87bn
Gross profit₩60.22bn₩64.41bn₩69.56bn₩68.84bn₩73.31bn₩70.50bn₩69.66bn₩68.70bn
Operating income₩3.31bn−₩648.7m₩9.82bn₩9.87bn₩16.30bn₩12.85bn₩9.47bn₩8.68bn
Net income−₩247.5m₩339.3m₩10.85bn₩7.92bn₩11.58bn₩12.31bn₩3.94bn₩7.14bn
Diluted earnings per share-21.2429.12930.98680.01994.161,051.98333.69604.93
Cash from operations₩15.85bn₩19.01bn₩14.52bn₩10.92bn₩6.14bn₩13.42bn₩52.56bn₩35.41bn
Capital spending−₩9.50bn−₩6.95bn−₩9.19bn−₩8.00bn−₩4.30bn−₩2.82bn−₩84.21bn−₩70.32bn
Free cash flow₩6.34bn₩12.06bn₩5.33bn₩2.92bn₩1.84bn₩10.60bn−₩31.65bn−₩34.91bn
Total assets₩650.03bn₩661.34bn₩680.28bn₩644.23bn₩635.53bn₩604.86bn₩606.29bn₩585.34bn
Cash and short-term investments—————₩67.17bn₩68.87bn₩64.72bn
Debt₩49.94bn₩65.69bn₩82.32bn₩80.09bn₩68.45bn₩118.86bn₩132.10bn₩120.55bn
Shareholders' equity₩368.36bn₩370.53bn₩373.91bn₩368.18bn₩361.60bn₩351.52bn₩345.97bn₩341.66bn

Financial ratios

Data as of 2 Sept 2026

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017
Gross margin45.5%48.3%51.8%54.4%57.0%54.1%———
Operating margin8.6%6.5%10.1%7.7%10.4%13.3%———
Net margin6.9%5.0%9.1%4.6%7.0%13.7%———
Return on equity11.4%8.5%15.5%7.9%11.6%23.3%———
Return on assets6.3%4.9%9.4%4.7%7.0%13.3%———
Free cash flow yield——————29.2%14.8%26.5%
Revenue growth5.2%6.9%12.1%12.7%7.4%11.4%———
Earnings growth44.8%-41.6%124.9%-27.0%-44.7%45.5%———
Current ratio1.70x1.67x2.03x2.43x1.62x2.14x———
Debt to equity0.22x0.38x0.24x0.23x0.12x0.41x———
Equity ratio55.0%57.1%60.6%59.8%60.9%57.3%———
Interest coverage8.52x11.93x22.37x12.00x16.86x30.04x———
R&D as a share of sales6.7%5.9%6.0%7.4%7.1%6.5%———
Buybacks as a share of market value——————0.0%-43.8%—

Growth per year

Compound annual rate

3 years5 years10 years
Revenue8.0%8.8%—
Operating income12.0%-0.3%—
Net income23.9%-5.2%—

Average margins

Over each period

1 year3 years5 years10 years
Gross margin46.9%49.7%51.3%—

Valuation history

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Price to earnings7.511.09.015.418.412.011.511.710.025.7
Price to sales0.50.60.80.71.31.61.21.61.22.3

Dividends and splits

Per share, in the currency the company pays

Paid for 9 years. Last went ex-dividend on 28 Aug 2026.

FY2026FY2025FY2024FY2023FY2022FY2021FY2020FY2019
Paid in the year600.001,050.00630.00300.00600.00600.00495.868525.921
  • 11-for-10 split · 29 Dec 2021
  • 11-for-10 split · 29 Dec 2020
  • 11-for-10 split · 27 Dec 2019
  • 11-for-10 split · 27 Dec 2018
  • 6-for-5 split · 15 May 2018
  • 11-for-10 split · 27 Dec 2017

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.